https://www.selleckchem.com/products/q-vd-oph.html
s, especially the miRNA panel, could predict the HCC patient's prognosis. © 2020 Wang et al.Introduction Despite the increased utilization of pharmacogenetic (PGt) testing to guide drug therapy, little is known about the ethical challenges posed by the use of these genetic tools. Methods This cross-sectional study aimed to address ethical issues related to ancillary genetic information, consent forms, and potential confidentiality breaches from physicians' perspectives. A questionnaire was administered to all practicing physicians work
Like
Comment
Share
